1. Home
  2. EQPT vs APLS Comparison

EQPT vs APLS Comparison

Compare EQPT & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EQPT

EquipmentShare.com Inc Common Stock

N/A

Current Price

$20.11

Market Cap

5.4B

Sector

N/A

ML Signal

N/A

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$40.42

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQPT
APLS
Founded
2015
2009
Country
United States
United States
Employees
8206
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
EQPT
APLS
Price
$20.11
$40.42
Analyst Decision
Buy
Hold
Analyst Count
9
21
Target Price
$40.50
$32.71
AVG Volume (30 Days)
1.4M
6.6M
Earning Date
03-18-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
112.50
EPS
N/A
0.20
Revenue
N/A
$1,003,782,000.00
Revenue This Year
$20.16
N/A
Revenue Next Year
$24.12
$18.21
P/E Ratio
N/A
$202.08
Revenue Growth
N/A
28.46
52 Week Low
$18.80
$16.10
52 Week High
$35.50
$40.48

Technical Indicators

Market Signals
Indicator
EQPT
APLS
Relative Strength Index (RSI) 32.57 87.61
Support Level $19.61 $19.38
Resistance Level $34.95 N/A
Average True Range (ATR) 1.73 0.54
MACD -0.05 2.77
Stochastic Oscillator 20.36 99.70

Price Performance

Historical Comparison
EQPT
APLS

About EQPT EquipmentShare.com Inc Common Stock

EquipmentShare.com Inc is a vertically integrated platform that combines proprietary technology, a connected equipment fleet, and a nationwide footprint to serve the construction industry. The company operates its business through the following reportable segments: Equipment Rental and Services Operations, comprised of recurring activity performed at full-service branch locations, such as equipment rentals and related services, and sales of parts, supplies, and maintenance services to construction contractors and others. Equipment Sales, sales of new or used equipment made at any of the branch locations and dealership sites, including equipment sales to participants in the OWN Program.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).

Share on Social Networks: